Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$20.60
Last update: Nov 18, 7:08 AM
Comments
Loading...
Phreesia Analyst Ratings and Price Targets | NYSE:PHR | Benzinga
Phreesia Inc has a consensus price target of $33.65 based on the ratings of 23 analysts. The high is $40 issued by Baird on June 2, 2023. The low is $28 issued by JP Morgan on September 9, 2024. The 3 most-recent analyst ratings were released by BMO Capital, Keybanc, and Truist Securities on November 13, 2025, October 8, 2025, and September 8, 2025, respectively. With an average price target of $33.33 between BMO Capital, Keybanc, and Truist Securities, there's an implied 61.81% upside for Phreesia Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
BMO Capital
Keybanc
Truist Securities
JMP Securities
Canaccord Genuity
1calculated from analyst ratings
Analyst Ratings for Phreesia
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/13/2025 | 55.34% | BMO Capital | → $32 | Initiates | → Outperform | |||
10/08/2025 | 55.34% | Keybanc | $35 → $32 | Maintains | Overweight | |||
09/08/2025 | 74.76% | Truist Securities | $35 → $36 | Maintains | Buy | |||
09/08/2025 | 65.05% | JMP Securities | $30 → $34 | Maintains | Market Outperform | |||
09/05/2025 | 84.47% | Canaccord Genuity | $34 → $38 | Maintains | Buy | |||
09/05/2025 | 65.05% | Piper Sandler | $33 → $34 | Maintains | Overweight | |||
09/05/2025 | 60.19% | DA Davidson | → $33 | Assumes | Buy → Buy | |||
09/05/2025 | 69.9% | Needham | $29 → $35 | Maintains | Buy | |||
09/03/2025 | 55.34% | Stephens & Co. | $32 → $32 | Reiterates | Overweight → Overweight | |||
08/27/2025 | 74.76% | Mizuho | → $36 | Initiates | → Outperform | |||
07/14/2025 | 69.9% | Keybanc | $28 → $35 | Maintains | Overweight | |||
05/29/2025 | 69.9% | Truist Securities | $34 → $35 | Maintains | Buy | |||
05/29/2025 | 65.05% | Canaccord Genuity | $35 → $34 | Maintains | Buy | |||
04/16/2025 | 35.92% | Keybanc | $30 → $28 | Maintains | Overweight | |||
04/14/2025 | 65.05% | DA Davidson | $36 → $34 | Maintains | Buy | |||
03/13/2025 | 69.9% | Canaccord Genuity | $34 → $35 | Maintains | Buy | |||
03/13/2025 | 40.78% | Needham | $29 → $29 | Reiterates | Buy → Buy | |||
01/29/2025 | 60.19% | Piper Sandler | $31 → $33 | Reiterates | Overweight → Overweight | |||
01/10/2025 | 69.9% | Citigroup | $31 → $35 | Maintains | Buy | |||
01/10/2025 | 40.78% | Needham | $29 → $29 | Reiterates | Buy → Buy | |||
01/08/2025 | 45.63% | Keybanc | $28 → $30 | Maintains | Overweight | |||
01/08/2025 | 55.34% | RBC Capital | $24 → $32 | Upgrade | Sector Perform → Outperform | |||
12/11/2024 | 65.05% | Truist Securities | $31 → $34 | Maintains | Buy | |||
12/11/2024 | 45.63% | Baird | $34 → $30 | Maintains | Outperform | |||
12/10/2024 | 45.63% | JMP Securities | $30 → $30 | Reiterates | Market Outperform → Market Outperform | |||
12/10/2024 | 40.78% | Needham | $29 → $29 | Reiterates | Buy → Buy | |||
09/27/2024 | 11.65% | RBC Capital | $23 → $23 | Reiterates | Sector Perform → Sector Perform | |||
09/09/2024 | 35.92% | JP Morgan | $27 → $28 | Maintains | Overweight | |||
09/06/2024 | 50.49% | Truist Securities | $29 → $31 | Maintains | Buy | |||
09/06/2024 | 65.05% | Baird | $31 → $34 | Maintains | Outperform | |||
09/05/2024 | 45.63% | JMP Securities | $30 → $30 | Reiterates | Market Outperform → Market Outperform | |||
09/05/2024 | 11.65% | RBC Capital | $23 → $23 | Reiterates | Sector Perform → Sector Perform | |||
09/05/2024 | 65.05% | Canaccord Genuity | $34 → $34 | Maintains | Buy | |||
09/05/2024 | 55.34% | DA Davidson | $32 → $32 | Maintains | Buy | |||
09/05/2024 | 40.78% | Needham | $29 → $29 | Reiterates | Buy → Buy | |||
08/30/2024 | 45.63% | JMP Securities | $30 → $30 | Reiterates | Market Outperform → Market Outperform | |||
07/11/2024 | 21.36% | Keybanc | $27 → $25 | Maintains | Overweight | |||
07/01/2024 | 40.78% | Truist Securities | $29 → $29 | Maintains | Buy | |||
06/05/2024 | 31.07% | JP Morgan | $28 → $27 | Maintains | Overweight | |||
06/03/2024 | 40.78% | Truist Securities | $35 → $29 | Maintains | Buy | |||
05/31/2024 | 65.05% | Canaccord Genuity | $37 → $34 | Maintains | Buy | |||
05/31/2024 | 35.92% | Stephens & Co. | $28 → $28 | Reiterates | Overweight → Overweight | |||
05/31/2024 | 45.63% | JMP Securities | $30 → $30 | Reiterates | Market Outperform → Market Outperform | |||
05/31/2024 | 40.78% | Needham | $29 → $29 | Reiterates | Buy → Buy | |||
03/22/2024 | 35.92% | Stephens & Co. | $28 → $28 | Reiterates | Overweight → Overweight | |||
03/21/2024 | 11.65% | RBC Capital | $23 → $23 | Reiterates | Sector Perform → Sector Perform | |||
03/21/2024 | 45.63% | JMP Securities | $28 → $30 | Maintains | Market Outperform | |||
03/18/2024 | 50.49% | Baird | $30 → $31 | Maintains | Outperform | |||
03/15/2024 | 55.34% | DA Davidson | $32 → $32 | Maintains | Buy | |||
03/15/2024 | 40.78% | Needham | $29 → $29 | Reiterates | Buy → Buy | |||
03/15/2024 | 35.92% | JMP Securities | $28 → $28 | Reiterates | Market Outperform → Market Outperform | |||
03/15/2024 | 11.65% | RBC Capital | $17 → $23 | Maintains | Sector Perform | |||
03/15/2024 | 45.63% | Raymond James | $25 → $30 | Reiterates | Outperform → Outperform | |||
03/15/2024 | 79.61% | Canaccord Genuity | $36 → $37 | Maintains | Buy | |||
03/12/2024 | 35.92% | JMP Securities | $28 → $28 | Reiterates | Market Outperform → Market Outperform | |||
02/26/2024 | 69.9% | Truist Securities | → $35 | Initiates | → Buy | |||
01/18/2024 | 40.78% | Needham | $29 → $29 | Reiterates | Buy → Buy | |||
01/03/2024 | 40.78% | Barclays | → $29 | Initiates | → Overweight | |||
12/07/2023 | 21.36% | Raymond James | $30 → $25 | Maintains | Outperform | |||
12/07/2023 | 45.63% | Keybanc | $40 → $30 | Maintains | Overweight | |||
12/06/2023 | 35.92% | JMP Securities | $39 → $28 | Maintains | Market Outperform | |||
12/06/2023 | 40.78% | Needham | $40 → $29 | Maintains | Buy | |||
09/12/2023 | 94.17% | Piper Sandler | $43 → $40 | Maintains | Overweight | |||
09/11/2023 | 45.63% | Raymond James | $40 → $30 | Maintains | Outperform | |||
09/08/2023 | 69.9% | Stephens & Co. | → $35 | Reiterates | Overweight → Overweight | |||
09/07/2023 | 108.74% | Canaccord Genuity | $46 → $43 | Maintains | Buy | |||
09/07/2023 | 79.61% | Citigroup | $40 → $37 | Maintains | Buy | |||
09/07/2023 | 40.78% | RBC Capital | $33 → $29 | Maintains | Sector Perform | |||
09/07/2023 | 79.61% | Stephens & Co. | → $37 | Reiterates | Overweight → Overweight | |||
09/07/2023 | 94.17% | Needham | → $40 | Reiterates | Buy → Buy | |||
09/01/2023 | 123.3% | Canaccord Genuity | → $46 | Reiterates | Buy → Buy | |||
08/15/2023 | 79.61% | Stephens & Co. | → $37 | Reiterates | Overweight → Overweight | |||
06/06/2023 | 79.61% | Stephens & Co. | → $37 | Reiterates | Overweight → Overweight | |||
06/02/2023 | 94.17% | Baird | $41 → $40 | Maintains | Outperform | |||
06/01/2023 | 60.19% | RBC Capital | → $33 | Reiterates | Sector Perform → Sector Perform | |||
06/01/2023 | 89.32% | JMP Securities | → $39 | Reiterates | → Market Outperform | |||
06/01/2023 | 79.61% | Stephens & Co. | → $37 | Reiterates | Overweight → Overweight | |||
06/01/2023 | 94.17% | Needham | → $40 | Reiterates | Buy → Buy | |||
05/25/2023 | 94.17% | Keybanc | $45 → $40 | Maintains | Overweight | |||
04/12/2023 | 79.61% | Stephens & Co. | → $37 | Initiates | → Overweight | |||
03/29/2023 | 94.17% | Guggenheim | $35 → $40 | Maintains | Buy | |||
03/23/2023 | 45.63% | DA Davidson | $28 → $30 | Maintains | Neutral | |||
03/23/2023 | 60.19% | RBC Capital | $26 → $33 | Maintains | Sector Perform | |||
03/23/2023 | 89.32% | JMP Securities | $34 → $39 | Maintains | Outperform | |||
03/23/2023 | 94.17% | Needham | → $40 | Reiterates | → Buy | |||
03/22/2023 | 99.03% | Baird | $41 → $41 | Maintains | Outperform | |||
03/20/2023 | 94.17% | Needham | → $40 | Reiterates | → Buy | |||
02/02/2023 | 118.45% | Keybanc | $40 → $45 | Maintains | Overweight | |||
01/25/2023 | 108.74% | Piper Sandler | $37 → $43 | Maintains | Overweight | |||
01/05/2023 | 89.32% | SVB Leerink | $34 → $39 | Maintains | Outperform | |||
01/04/2023 | 94.17% | Needham | $35 → $40 | Maintains | Buy | |||
12/14/2022 | 99.03% | Baird | $37 → $41 | Maintains | Outperform | |||
12/13/2022 | 94.17% | Citigroup | → $40 | Upgrade | Neutral → Buy | |||
12/12/2022 | 94.17% | Raymond James | $35 → $40 | Maintains | Outperform | |||
12/09/2022 | 79.61% | Baird | $36 → $37 | Maintains | Outperform | |||
12/09/2022 | 26.21% | RBC Capital | $22 → $26 | Maintains | Sector Perform | |||
12/09/2022 | 65.05% | SVB Leerink | $31 → $34 | Upgrade | Market Perform → Outperform | |||
12/05/2022 | 74.76% | Baird | $36 → $36 | Maintains | Outperform |
FAQ
What is the target price for Phreesia (PHR) stock?
The latest price target for Phreesia (NYSE:PHR) was reported by BMO Capital on November 13, 2025. The analyst firm set a price target for $32.00 expecting PHR to rise to within 12 months (a possible 55.34% upside). 26 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Phreesia (PHR)?
The latest analyst rating for Phreesia (NYSE:PHR) was provided by BMO Capital, and Phreesia initiated their outperform rating.
When was the last upgrade for Phreesia (PHR)?
The last upgrade for Phreesia Inc happened on January 8, 2025 when RBC Capital raised their price target to $32. RBC Capital previously had a sector perform for Phreesia Inc.
When was the last downgrade for Phreesia (PHR)?
There is no last downgrade for Phreesia.
When is the next analyst rating going to be posted or updated for Phreesia (PHR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Phreesia, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Phreesia was filed on November 13, 2025 so you should expect the next rating to be made available sometime around November 13, 2026.
Is the Analyst Rating Phreesia (PHR) correct?
While ratings are subjective and will change, the latest Phreesia (PHR) rating was a initiated with a price target of $0.00 to $32.00. The current price Phreesia (PHR) is trading at is $20.60, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
